[Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
D000293:Adolescent; D000367:Age Factors; D000583:Amikacin / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D001806:Blood Urea Nitrogen; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007612:Kanamycin / Q000031:analogs & derivatives*; D008099:Liver / Q000503:physiopathology; D008297:Male; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014917:Whooping Cough / Q000188:drug therapy*
D007612:Kanamycin; D000583:Amikacin